Home
News
Create
Screeners
Insights
Centenial Surgical Suture
82.
50
-1.50
(-1.79%)
Market Cap
₹30.05 Cr
PE Ratio
-13.91
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.79%
1M
+7.14%
6M
-11.48%
1Y
-47.54%
5Y
+41.39%
View Company Insights
Latest news about Centenial Surgical Suture
Centenial Surgical Suture Ltd Sanjay Sohani retires as President
Jun 24, 2026
Centenial Surgical Suture Ltd announced the retirement of Mr. Sanjay Sohani, President - Production, effective June 20, 2026. He has ceased to be a Senior Management Personnel of the company. The disclosure was made in compliance with SEBI LODR Regulations.
Centenial Surgical Suture closes trading window ahead of Q1FY27 results
Jun 23, 2026
Centennial Surgical Suture reports net loss for FY26
Jun 03, 2026
Centenial Surgical board meets on May 30 for FY26 results
May 23, 2026
Centenial Surgical Suture Ltd Submits Q4FY26 Compliance Certificate Under SEBI Depositories Regulations
Apr 16, 2026
More news about Centenial Surgical Suture
17
Mar 26
Centenial Surgical Suture Ltd Alleges Price Manipulation in Response to BSE Surveillance Inquiry
Centenial Surgical Suture Ltd responded to BSE surveillance inquiry dated March 13, 2026, alleging systematic price manipulation through suspicious small-lot transactions by investors across India. The company provided detailed trading data from January-March 2026 and requested comprehensive investigation, emphasizing no material announcements justified the price movements and confirming management has no involvement in the alleged activities.
17
Feb 26
Centenial Surgical Suture Files BSE Complaint Alleging Price Manipulation in Scrip 531308
Centenial Surgical Suture Ltd has filed a formal complaint with BSE alleging price manipulation in scrip 531308 during February 06-13, 2026. The company reported suspicious small-volume trading activities and requested investigation into potential SEBI regulation violations, while denying any involvement by company insiders in the alleged manipulative practices.
12
Feb 26
Centenial Surgical Suture Ltd. Board Approves Q3FY26 Financial Results
Centenial Surgical Suture Ltd. board approved standalone unaudited financial results for the quarter and nine months ended December 31, 2025, during a 20-minute meeting on February 12, 2026. The approval was conducted in compliance with Regulation 33 of SEBI (LODR) Regulations, 2015, with proper regulatory disclosure made to BSE Limited.
10
Oct 25
Centenial Surgical Suture Ltd Strengthens Audit Committee with New Appointment
Centenial Surgical Suture Ltd has appointed Neel Vora, an Independent Non-Executive Director, to its Audit Committee effective October 10, 2025. The appointment was made through a Circular Resolution passed by the Board of Directors. The reconstituted Audit Committee now comprises four members: Akash Modi (Chairman), Ridhima Limaye, Neel Vora, and Vijay Majrekar. This change aligns with the company's efforts to maintain high standards of financial oversight and transparency.
Centenial Surgical Suture
82.
50
-
1.
50
(-
1.
79
%)
1 Year Returns:
-47.54%
Industry Peers
Poly Medicure
1,715.60
(+
3.
08
%)
Tarsons Products
298.25
(-
3.
40
%)
Q-Line Biotech
552.40
(+
2.
49
%)
Laxmi Dental
222.81
(+
0.
72
%)
Osel Devices
439.95
(-
0.
69
%)
Fabtech Technologies
157.92
(-
0.
11
%)
Vasa Denticity
388.25
(+
3.
26
%)
Hemant Surgical Industries
376.95
(-
0.
28
%)
Prevest Denpro
388.00
(+
1.
13
%)
Aprameya Engineering
149.95
(-
0.
73
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar